Dentsply Sirona (XRAY) Net Income towards Common Stockholders (2009 - 2026)
Dentsply Sirona (XRAY) posted Net Income towards Common Stockholders of -$10.0 million for Q1 2026, up 93.1% on a QoQ basis from -$145.0 million in Q4 2025, and down 152.63% year-over-year from $19.0 million in Q1 2025.
Dentsply Sirona (XRAY) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Dentsply Sirona's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at -$10.0 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 152.63% year-over-year to -$10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$627.0 million (up 30.95% YoY) and the FY2025 annual result came in at -$598.0 million, up 34.29% from the prior year.
- Net Income towards Common Stockholders was -$10.0 million for Q1 2026 at Dentsply Sirona, up from -$145.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $85.0 million in Q2 2023 and bottomed at -$1.1 billion in Q3 2022.
- A 5-year average of -$152.9 million and a median of -$15.0 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders sank 1382.14% — and 2023, when it soared 580.0%.
- Dentsply Sirona's Net Income towards Common Stockholders stood at -$15.0 million in 2022, then surged by 580.0% to $72.0 million in 2023, then plunged by 694.44% to -$428.0 million in 2024, then jumped by 66.12% to -$145.0 million in 2025, then jumped by 93.1% to -$10.0 million in 2026.
- Business Quant data shows XRAY's Net Income towards Common Stockholders at -$10.0 million in Q1 2026, -$145.0 million in Q4 2025, and -$428.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.54 Bn | 121.33 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.82 Bn | 44.00 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.93 Bn | 31.28 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.92 Bn | 30.68 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.40 Bn | 22.97 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.04 Bn | 13.48 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Dentsply Sirona | 2.63 Bn | 2.44 Bn | 427.00 Mn | -10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.00 Mn |
| Dec 31, 2025 | -145.00 Mn |
| Sep 30, 2025 | -428.00 Mn |
| Jun 30, 2025 | -44.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | -428.00 Mn |
| Sep 30, 2024 | -495.00 Mn |
| Jun 30, 2024 | -4.00 Mn |
| Mar 31, 2024 | 17.00 Mn |
| Dec 31, 2023 | 72.00 Mn |
| Sep 30, 2023 | -266.00 Mn |
| Jun 30, 2023 | 85.00 Mn |
| Mar 31, 2023 | -23.00 Mn |
| Dec 31, 2022 | -15.00 Mn |
| Sep 30, 2022 | -1.08 Bn |
| Jun 30, 2022 | 73.00 Mn |
| Mar 31, 2022 | 69.00 Mn |
| Dec 31, 2021 | 119.00 Mn |
| Sep 30, 2021 | 84.00 Mn |
| Jun 30, 2021 | 96.00 Mn |